2012 Fiscal Year Final Research Report
Development of multi-lateral cancer gene therapy by enhancing anti-tumor activity of inactivated Sendai virus particle
| Project/Area Number |
22300339
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (B)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Clinical oncology
|
|---|
| Research Institution | Osaka University |
|---|
Principal Investigator |
KANEDA Yasufumi 大阪大学, 大学院・医学系研究科, 教授 (10177537)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
TANEMURA Atsushi 大阪大学, 大学院・医学系研究科, 助教 (50457016)
|
|---|
| Project Period (FY) |
2010 – 2012
|
| Keywords | HVJ / 癌 / 抗腫瘍免疫 / アポトーシス / 遺伝子解析 / 遺伝子治療 |
|---|
| Research Abstract |
We have reported that UV-inactivated Sendai virus particles (hemagglutinating virus of Japan envelope; HVJ-E) have multiple anti-tumor activities. Clinical application of HVJ-E has been started to evaluate the safety and efficacy of the particle in cancer patients. To enhance the anti-tumor activities, we attempted to incorporate therapeutic molecules into HVJ-E. As a result, HVJ-E containing IL2 or IL-12 gene enhanced anti-tumor immunity. HVJ-E having IL-12 polypeptide on the surface was developed and was more effective for the treatment of melanoma than original HVJ-E alone. Rad51 siRNA incorporated into HVJ-E augmented the effect of cancer treatment when combined with anti-tumor reagent, dacarbazine.
|
Research Products
(9 results)
-
-
-
[Journal Article] Immunogene therapy using immunomodulating HVJ-E vector augments anti-tumor effects in murine malignant glioma.2011
Author(s)
Matsuda, M., Nimura, K., Shimbo, T., Hamasaki, T., Yamamoto, T., Matsumura, A. and Kaneda, Y
-
Journal Title
J. Neuro-Oncology
Volume: 103
Pages: 19-31
Peer Reviewed
-
-
-
-
-
-
